A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris
Clinical trial NCT01631474 · COMPLETED
Trial details
- NCT number
- NCT01631474
- Sponsor
- Intrepid Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2014-02-01
- Enrollment
- 363
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.